Observed and projected prevalence of prurigo nodularis in a commercially and Medicare-insured US population

被引：0
|
作者：
Gabriel, Sylvie [1 ]
Kwatra, Shawn G. [2 ]
Puelles, Jorge [3 ]
机构：
[1] Galderma, Lausanne, Switzerland
[2] Johns Hopkins Univ Sch Med, Baltimore, MD USA
[3] Galderma SA, La Tour De Peilz, Vaud, Switzerland
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
34095
引用
收藏
页码：AB86 / AB86
页数：1
相关论文
共 50 条
  • [41] Prevalence and comorbidity burden of prurigo nodularis in United States adults enrolled in the All of Us research program
    Joel, Marina Z.
    Hydol-Smith, Jourdan
    Kambala, Anusha
    Cornman, Hannah L.
    Kwatra, Shawn G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (05) : 1056 - 1058
  • [42] Incidence of Second Primary Malignancies in Medicare-Insured Patients in the US with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
    Ailawadhi, Sikander
    Delea, Thomas
    Moynahan, Aaron
    Ge, Wenzhen
    Hampp, Christian
    Archambault, Alexi
    Wu, Ning
    Lorenc, Karen Rodriguez
    Noguera-Troise, Irene
    Kroog, Glenn S.
    Houvras, Yariv
    Ma, Qiufei
    BLOOD, 2023, 142
  • [43] Real-World Effectiveness of Once-Weekly Semaglutide (Sema OW) from a US Commercially Insured and Medicare Advantage Population
    Visaria, Jay
    Uzoigwe, Chioma
    Swift, Caroline
    Paprocki, Yurek M.
    Willey, Vincent
    DIABETES, 2020, 69
  • [44] Real-World Effectiveness of Once-Weekly Semaglutide (sema OW) from a US Commercially Insured and Medicare Advantage Population
    Willey, Vincent
    Shivappa, Nitin
    Noone, Joshua
    Swift, Caroline
    Du, Simo
    Yurek, M. Paprocki .
    Tan, Hiangkiat
    DIABETES, 2021, 70
  • [45] Management patterns and costs of atrial fibrillation in a large commercially insured US population
    Fidan, D
    Ollendorf, D
    Leguet, P
    Gabriel, S
    Boccuzzi, S
    VALUE IN HEALTH, 2005, 8 (06) : A92 - A92
  • [46] Burden of acute myeloid leukemia (AML) in a US commercially insured population.
    Hagiwara, May
    Sharma, Arati
    Chung, Karen C.
    Delea, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Cost of Treatment in a US Commercially Insured, HIV-1-Infected Population
    Solem, Caitlyn T.
    Snedecor, Sonya J.
    Khachatryan, Alexandra
    Nedrow, Katherine
    Tawadrous, Margaret
    Chambers, Richard
    Haider, Seema
    Simpson, Kit
    PLOS ONE, 2014, 9 (05):
  • [48] Systemic overuse of health care in a commercially insured US population, 2010–2015
    Allison H. Oakes
    Hsien-Yen Chang
    Jodi B. Segal
    BMC Health Services Research, 19
  • [49] Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured US Population
    Peckham, Alyssa M.
    Evoy, Kirk E.
    Covvey, Jordan R.
    Ochs, Leslie
    Fairman, Kathleen A.
    Sclar, David A.
    PHARMACOTHERAPY, 2018, 38 (04): : 436 - 443
  • [50] Recent Pattern of H. pylori Testing in a Commercially Insured US Population
    Wang, Tao
    Meyers, Juliana
    Madhwani, Shweta
    Boklage, Susan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S662 - S662
12345